We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Sepracor, Barr Clash Over Asthma Drug

Law360 (July 16, 2007, 12:00 AM EDT) -- Sepracor Inc. has asserted five patents against generic drug maker Barr Laboratories Inc. in a bid to stave off competition in the $600 million annual market for the inhaled asthma treatment...
To view the full article, register now.